Synapse

← JHEP Reports

Papers in JHEP Reports

Page 11 · newest first

  1. Neoadjuvant atezolizumab plus bevacizumab prior liver transplantation for hepatocellular carcinomaJHEP Reports · 2024
  2. Macrophage Notch1 signaling modulates regulatory T cells via the TGFB axis in early MASLDJHEP Reports · 2024
  3. Deep metabolic phenotyping of humans with protein-altering variants in TM6SF2 using a genome-first approachJHEP Reports · 2024
  4. Mechanisms and implications of recompensation in cirrhosisJHEP Reports · 2024
  5. The future of clinical trials of gut microbiome therapeutics in cirrhosisJHEP Reports · 2024
  6. Second-line treatment patterns and outcomes in advanced HCC after progression on atezolizumab/bevacizumabJHEP Reports · 2024
  7. Hepatocellular carcinoma risk scores for non-viral liver disease: A systematic review and meta-analysisJHEP Reports · 2024
  8. Distinct virologic trajectories in chronic hepatitis B identify heterogeneity in response to nucleos(t)ide analogue therapyJHEP Reports · 2024
  9. Progressive Systemic Inflammation Precedes Decompensation in Compensated CirrhosisJHEP Reports · 2024
  10. Loss of Cdkn1a protects against MASLD alone or with alcohol intake by preserving lipid homeostasisJHEP Reports · 2024
  11. Soluble TREM2 reflects liver fibrosis status and predicts postoperative liver dysfunction after liver surgeryJHEP Reports · 2024
  12. PPARα suppresses growth of hepatocellular carcinoma in a high-fat diet context by reducing neutrophil extracellular trap releaseJHEP Reports · 2024
  13. Induction of phospholipase A2 group 4C by HCV infection regulates lipid droplet formationJHEP Reports · 2024
  14. Hepatic stellate cell single cell atlas reveals a highly similar activation process across liver disease aetiologiesJHEP Reports · 2024
  15. Molecular imaging of macrophage composition and dynamics in MASLDJHEP Reports · 2024
  16. Application of a deep learning algorithm for the diagnosis of HCCJHEP Reports · 2024
  17. Microcystin-RR is a biliary toxin selective for neonatal extrahepatic cholangiocytesJHEP Reports · 2024
  18. Tumor burden with AFP improves survival prediction for TACE-treated patients with HCC: An international observational study☆JHEP Reports · 2024
  19. ALDH1L2 drives HCC progression through TAM polarizationJHEP Reports · 2024
  20. Biliary atresia susceptibility gene EFEMP1 regulates extrahepatic bile duct elastic fiber formation and mechanicsJHEP Reports · 2024
  21. Oncogenic role of PMEPA1 and its association with immune exhaustion and TGF-β activation in HCCJHEP Reports · 2024
  22. Virological markers for clinical trials in chronic viral hepatitisJHEP Reports · 2024
  23. A home-based exercise programme attenuates fatigue in primary biliary cholangitis: Results from the EXCITED clinical trialJHEP Reports · 2024
  24. Use of artificial intelligence for liver diseases: A survey from the EASL congress 2024JHEP Reports · 2024
  25. Liver stiffness measurement predicts clinical outcomes in autoimmune hepatitisJHEP Reports · 2024
  26. Metabolomic profiles differentiate between porto-sinusoidal vascular disorder, liver cirrhosis, and healthy individualsJHEP Reports · 2024
  27. Quantification of alcohol intake in patients with steatotic liver disease and excessive alcohol intakeJHEP Reports · 2024
  28. Predicting Liver Ablation Volumes with Real-Time MRI Thermometry Real-time MRI-thermometry of microwave ablationJHEP Reports · 2024
  29. Deep learning helps discriminate between autoimmune hepatitis and primary biliary cholangitisJHEP Reports · 2024
  30. Hic-5 antisense oligonucleotide inhibits advanced hepatic fibrosis and steatosis in vivoJHEP Reports · 2024
  31. Understanding the complex macrophage landscape in MASLDJHEP Reports · 2024
  32. Development of Mutated β-catenin Gene Signature to identify CTNNB1 mutations from whole and spatial transcriptomic data in patients with HCCJHEP Reports · 2024
  33. Essential roles of B-cell subsets in the progression of MASLD and HCCJHEP Reports · 2024
  34. Differential Prevalence and Prognostic value of Metabolic Syndrome Components Among MASLD PatientsJHEP Reports · 2024
  35. Differential effects of low or high-fat dairy and fat derived from dairy products on MASLDJHEP Reports · 2024
  36. Heterogeneity in adverse events related to Atezolizumab-Bevacizumab for hepatocellular carcinoma reported in real-life studiesJHEP Reports · 2024
  37. Palmitoylcarnitine impairs immunity in decompensated cirrhosisJHEP Reports · 2024
  38. Patient and physician expectation’s regarding disease and treatment of advanced HCC: the prospective PERCEPTION1 studyJHEP Reports · 2024
  39. Impact of SARS-CoV-2 Vaccination in Patients with Vascular Liver Diseases: Observations from a VALDIG Multicenter StudyJHEP Reports · 2024
  40. Fecal deoxycholic acid associates with diet, intestinal microbes and total bilirubin in primary sclerosing cholangitisJHEP Reports · 2024
  41. A Novel Multisite Model to Facilitate Hepatitis C Virus Elimination in People Experiencing HomelessnessJHEP Reports · 2024
  42. Lipid metabolism in MASLD and MASH: From mechanism to the clinicJHEP Reports · 2024
  43. Albumin Reprograms the B cell Transcriptional Landscape and Improves Neutrophil Antimicrobial Function in Patients with Decompensated Cirrhosis.JHEP Reports · 2024
  44. Altered fatty acid metabolism rewires cholangiocarcinoma stemness featuresJHEP Reports · 2024
  45. Liver resection and transplantation in the era of checkpoint inhibitorsJHEP Reports · 2024
  46. ALT levels, alcohol use and metabolic risk factors have prognostic relevance for liver-related outcomes in the general populationJHEP Reports · 2024
  47. Diagnostic and prognostic performance of the LiverRisk score in tertiary careJHEP Reports · 2024
  48. Persistent Varices in Cured Patients: Understanding the role of Hepatic Venous Pressure GradientJHEP Reports · 2024
  49. Inflammation in liver fibrosis and atrial fibrillation: a prospective population-based proteomic studyJHEP Reports · 2024
  50. Loss of biochemical response at any time worsens outcomes in UDCA-treated patients with primary biliary cholangitisJHEP Reports · 2024